GHRP-2 vs Hexarelin

Overview

GHRP-2 and hexarelin are both potent growth hormone releasing peptides (GHRPs) that stimulate GH release via the ghrelin receptor. Both are considered highly effective for GH stimulation, but hexarelin is notably the most potent GHRP while also carrying higher desensitization risk. Neither is FDA-approved.

Key Facts

Aspect	GHRP-2	Hexarelin
Class	GHRP	GHRP
Structure	6 amino acids	6 amino acids
Target	GHS-R1a	GHS-R1a
FDA Status	Not approved	Not approved
Relative Potency	High	Highest

Mechanism Comparison

Aspect	GHRP-2	Hexarelin
Receptor	GHS-R1a (ghrelin)	GHS-R1a (ghrelin)
GH Release	Strong	Strongest
Cortisol Effect	Increases	Increases
Prolactin Effect	Increases	Increases
Cardiac Effects	Not emphasized	Some research

GH Release Comparison

Parameter	GHRP-2	Hexarelin
GH Increase	3-6x baseline	4-7x baseline
Potency Rank	#2-3	#1
Time to Peak	15-30 minutes	15-30 minutes
Duration	2-3 hours	2-3 hours

Hexarelin consistently shows the highest GH release among GHRPs in comparative studies.

Desensitization Comparison

Factor	GHRP-2	Hexarelin
Desensitization Risk	Moderate	High
Time to Desensitize	Weeks-months	Weeks
Recovery Period	Moderate	Longer
Cycling Needed	Recommended	Strongly recommended

Desensitization Concern

Hexarelin’s main drawback is receptor desensitization:

• Response diminishes with chronic use
• May require cycling (on/off periods)
• Recovery takes time after discontinuation
• GHRP-2 has more sustainable response

Evidence Comparison

Aspect	GHRP-2	Hexarelin
Human Studies	Limited	Moderate
Cardiac Research	Minimal	Notable
Publication Quality	Low-moderate	Low-moderate
Development Status	Abandoned	Abandoned

Hexarelin Cardiac Research

Hexarelin has unique research in cardiac function:

• Some studies show cardioprotective effects
• May act on cardiac receptors directly
• Research discontinued commercially
• Interest remains in academic settings

Side Effect Profile

GHRP-2

Effect	Likelihood	Notes
Cortisol elevation	Common	Moderate increase
Prolactin elevation	Common	Moderate increase
Appetite increase	Moderate	Less than GHRP-6
Water retention	Common	GH-related
Flushing	Common	Post-injection

Hexarelin

Effect	Likelihood	Notes
Cortisol elevation	Common	Significant
Prolactin elevation	Common	Significant
Appetite increase	Moderate	Less than GHRP-6
Water retention	Common	Due to strong GH
Desensitization	High concern	Key limitation
Flushing	Common	Post-injection

Comparative Profile

Effect	GHRP-2	Hexarelin	Ipamorelin
GH Potency	+++	++++	++
Cortisol	++	++	+
Prolactin	++	++	+
Desensitization	+	+++	+
Selectivity	Low	Low	High

Practical Considerations

When to Consider GHRP-2

• Potent GH release needed
• Longer-term use planned
• Desensitization concern
• Moderate appetite increase acceptable

When to Consider Hexarelin

• Maximum GH pulse desired
• Short-term/cycling protocol
• Cardiac research interest
• Willing to manage desensitization

Regulatory Status

Aspect	GHRP-2	Hexarelin
FDA Approval	No	No
Development	Abandoned	Abandoned
Availability	Research chemical	Research chemical
WADA Status	Prohibited	Prohibited
Quality Control	None	None

Administration (Research Context)

Aspect	GHRP-2	Hexarelin
Route	Subcutaneous	Subcutaneous
Cycling	Recommended	Strongly recommended

Combination Use

Both can be combined with GHRH analogs:

Combination	Notes
GHRP-2 + CJC-1295	Common, sustainable
Hexarelin + GHRH	Maximum pulse, cycling needed
Either + Ipamorelin	Rarely combined (same receptor)

Key Differences

Factor	GHRP-2	Hexarelin
GH Potency	High	Highest
Desensitization	Moderate risk	High risk
Sustainable Use	More sustainable	Requires cycling
Cardiac Interest	Minimal	Some research
Practical Choice	Longer protocols	Short-term maximum

Summary

• GHRP-2 offers potent GH release with more sustainable response over time
• Hexarelin is the most potent GHRP but carries significant desensitization risk
• Both elevate cortisol and prolactin (low selectivity)
• Hexarelin has unique cardiac research interest
• Cycling is strongly recommended for hexarelin
• Neither is FDA-approved; both are research chemicals only

---

This comparison is for educational purposes only. Neither peptide is approved for human use. Products sold are unregulated research chemicals with uncertain quality and safety.